Track the CARGO Therapeutics, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 3 July 2025 (Cession). Among the most active insiders: Radhakrishnan Anup. The full history is free.
16
Insider Decl.
n/a
Thresholds
€5m
1 ops.
Buy Volume
€105,832
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CARGO Therapeutics, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
30Σ signal
Buys €5m€105,832 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
CARGO Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It specializes in utilizing T cell technology to target tumors.